ID29792A - Formulasi lepas terkendali untuk mengobati corp - Google Patents

Formulasi lepas terkendali untuk mengobati corp

Info

Publication number: ID29792A
Authority: ID; Indonesia
Prior art keywords: corp; treat; controlled removal; removal formulation; formulation
Prior art date: 1999-02-23

Application number

IDW00200101812A

Other languages

English (en)

Inventor

Patrick G Faulkner

Jaime J Lucca

Thomas J Wrzosek

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-23

Filing date

2000-02-22

Publication date

2001-10-11

2000-02-22 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2001-10-11 Publication of ID29792A publication Critical patent/ID29792A/id

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Inorganic Chemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IDW00200101812A 1999-02-23 2000-02-22 Formulasi lepas terkendali untuk mengobati corp ID29792A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US12129199P	1999-02-23	1999-02-23

Publications (1)

Publication Number	Publication Date
ID29792A true ID29792A (id)	2001-10-11

Family

ID=22395738

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW00200101812A ID29792A (id)	1999-02-23	2000-02-22	Formulasi lepas terkendali untuk mengobati corp

Country Status (29)

Country	Link
US (1)	US20030211152A1 (id)
EP (1)	EP1154758A4 (id)
JP (1)	JP2002537320A (id)
KR (1)	KR20010112279A (id)
CN (1)	CN1195496C (id)
AR (1)	AR028986A1 (id)
AU (1)	AU3501500A (id)
BG (1)	BG105905A (id)
BR (1)	BR0008382A (id)
CA (1)	CA2366747A1 (id)
CO (1)	CO5150233A1 (id)
CZ (1)	CZ20013025A3 (id)
EA (1)	EA200100906A1 (id)
HK (1)	HK1043045A1 (id)
HU (1)	HUP0200134A3 (id)
ID (1)	ID29792A (id)
IL (1)	IL144603A0 (id)
MA (1)	MA25386A1 (id)
MY (1)	MY121142A (id)
NO (1)	NO20014049L (id)
NZ (1)	NZ527716A (id)
OA (1)	OA11836A (id)
PE (1)	PE20001496A1 (id)
PL (1)	PL350287A1 (id)
SK (1)	SK12072001A3 (id)
TR (1)	TR200102448T2 (id)
TW (1)	TWI224013B (id)
WO (1)	WO2000050011A1 (id)
ZA (1)	ZA200106803B (id)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AP2002002446A0 (en) *	1999-10-29	2002-03-31	Smithkline Beecham Corp	Method for administering a phosphodiesterase 4 inhibitor.
US20040146561A1 (en) *	2001-05-23	2004-07-29	Naoki Sakurai	Compositions for promoting healing of bone fracture
JP4510383B2 (ja) *	2001-05-23	2010-07-21	田辺三菱製薬株式会社	軟骨疾患修復治療用組成物
HUP0500078A3 (en) *	2001-09-19	2010-07-28	Nycomed Gmbh	Pharmaceutical composition containing a combination of a pde inhibitor and a leukotriene receptor antagonist
MY140561A (en)	2002-02-20	2009-12-31	Nycomed Gmbh	Dosage form containing pde 4 inhibitor as active ingredient
TWI328009B (en)	2003-05-21	2010-08-01	Glaxo Group Ltd	Quinoline derivatives as phosphodiesterase inhibitors
AU2003290394A1 (en) *	2003-09-30	2005-04-14	Lupin Ltd.	Extended release formulation of beta-lactam antibiotics
PE20060272A1 (es)	2004-05-24	2006-05-22	Glaxo Group Ltd	(2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
EP1781260B2 (en) *	2004-08-13	2014-04-02	Boehringer Ingelheim International GmbH	Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
GB0511066D0 (en) *	2005-05-31	2005-07-06	Novartis Ag	Organic compounds
GB0514809D0 (en)	2005-07-19	2005-08-24	Glaxo Group Ltd	Compounds
CN109908139B (zh) *	2018-12-28	2022-02-22	南京市儿童医院	西洛司特在制备用于治疗急性肾损伤相关病症的药物中的用途
EP3911304B1 (en) *	2019-01-15	2023-09-06	UNION therapeutics A/S	Modified release tablet formulations containing phosphodiesterase inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL297088A (id) *	1961-01-31
IL78017A (en) *	1986-03-03	1989-06-30	Yissum Res Dev Co	Sustained release tablets of theophylline
US5286494A (en) *	1986-07-02	1994-02-15	Schering Aktiengesellschaft	Medicinal agents with sustained action
NZ251092A (en) *	1992-04-02	1996-12-20	Smithkline Beecham Corp	4-cyano-cyclohexane derivatives; medicaments; used in treating asthma
GB9222253D0 (en) *	1992-10-23	1992-12-09	Celltech Ltd	Chemical compounds
US5672622A (en) *	1994-04-21	1997-09-30	Berlex Laboratories, Inc.	Treatment of multiple sclerosis
US5998428A (en) *	1995-05-31	1999-12-07	Smithkline Beecham Corporation	Compounds and methods for treating PDE IV-related diseases
US6210710B1 (en) *	1997-04-28	2001-04-03	Hercules Incorporated	Sustained release polymer blend for pharmaceutical applications
US5840329A (en) *	1997-05-15	1998-11-24	Bioadvances Llc	Pulsatile drug delivery system
AR035987A1 (es) *	1999-03-01	2004-08-04	Smithkline Beecham Corp	Uso de un compuesto inhibidor de la pde 4 para la manufactura de un medicamento y el medicamento para tratar asma inducida por ejercicio

2000
- 2000-02-21 AR ARP000100730A patent/AR028986A1/es not_active Application Discontinuation
- 2000-02-21 MY MYPI20000615A patent/MY121142A/en unknown
- 2000-02-22 JP JP2000600623A patent/JP2002537320A/ja not_active Withdrawn
- 2000-02-22 CA CA002366747A patent/CA2366747A1/en not_active Abandoned
- 2000-02-22 EP EP00913600A patent/EP1154758A4/en not_active Withdrawn
- 2000-02-22 EA EA200100906A patent/EA200100906A1/ru unknown
- 2000-02-22 AU AU35015/00A patent/AU3501500A/en not_active Abandoned
- 2000-02-22 WO PCT/US2000/004713 patent/WO2000050011A1/en not_active Application Discontinuation
- 2000-02-22 IL IL14460300A patent/IL144603A0/xx unknown
- 2000-02-22 CZ CZ20013025A patent/CZ20013025A3/cs unknown
- 2000-02-22 OA OA1200100217A patent/OA11836A/en unknown
- 2000-02-22 KR KR1020017010666A patent/KR20010112279A/ko not_active Application Discontinuation
- 2000-02-22 PL PL00350287A patent/PL350287A1/xx not_active Application Discontinuation
- 2000-02-22 HU HU0200134A patent/HUP0200134A3/hu unknown
- 2000-02-22 PE PE2000000135A patent/PE20001496A1/es not_active Application Discontinuation
- 2000-02-22 CN CNB008042098A patent/CN1195496C/zh not_active Expired - Fee Related
- 2000-02-22 NZ NZ527716A patent/NZ527716A/en unknown
- 2000-02-22 SK SK1207-2001A patent/SK12072001A3/sk unknown
- 2000-02-22 TR TR2001/02448T patent/TR200102448T2/xx unknown
- 2000-02-22 BR BR0008382-8A patent/BR0008382A/pt not_active IP Right Cessation
- 2000-02-22 ID IDW00200101812A patent/ID29792A/id unknown
- 2000-02-23 CO CO00012706A patent/CO5150233A1/es unknown
- 2000-03-15 TW TW089103003A patent/TWI224013B/zh not_active IP Right Cessation
2001
- 2001-08-17 ZA ZA200106803A patent/ZA200106803B/en unknown
- 2001-08-20 NO NO20014049A patent/NO20014049L/no unknown
- 2001-08-23 MA MA26303A patent/MA25386A1/fr unknown
- 2001-09-14 BG BG105905A patent/BG105905A/bg unknown
2002
- 2002-04-12 HK HK02102791.5A patent/HK1043045A1/zh unknown
2003
- 2003-06-12 US US10/460,613 patent/US20030211152A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CO5150233A1 (es)	2002-04-29
WO2000050011A1 (en)	2000-08-31
US20030211152A1 (en)	2003-11-13
CA2366747A1 (en)	2000-08-31
IL144603A0 (en)	2002-05-23
TWI224013B (en)	2004-11-21
NO20014049L (no)	2001-10-22
NZ527716A (en)	2005-03-24
TR200102448T2 (tr)	2003-03-21
EP1154758A1 (en)	2001-11-21
HUP0200134A3 (en)	2003-03-28
MA25386A1 (fr)	2002-04-01
PE20001496A1 (es)	2001-02-08
EA200100906A1 (ru)	2002-02-28
ZA200106803B (en)	2002-08-19
PL350287A1 (en)	2002-12-02
HK1043045A1 (zh)	2002-09-06
JP2002537320A (ja)	2002-11-05
AU3501500A (en)	2000-09-14
CZ20013025A3 (cs)	2002-07-17
CN1347314A (zh)	2002-05-01
KR20010112279A (ko)	2001-12-20
AR028986A1 (es)	2003-06-04
BR0008382A (pt)	2002-02-05
NO20014049D0 (no)	2001-08-20
BG105905A (bg)	2002-04-30
CN1195496C (zh)	2005-04-06
SK12072001A3 (sk)	2002-01-07
MY121142A (en)	2005-12-30
HUP0200134A2 (hu)	2002-05-29
EP1154758A4 (en)	2007-09-05
OA11836A (en)	2005-08-22

Publication	Publication Date	Title
ID25824A (id)	2000-11-09	Formulasi terapeutik untuk memberikan tolterodin dengan pelepasan yang terkendali
EP1267798A4 (en)	2004-01-28	TREATMENT OF SKIN DAMAGE WITH POLYENYLPHOSPHATIDYLCHOLINE
ID27825A (id)	2001-04-26	Sediaan lepas lambat
DE69924365D1 (de)	2005-04-28	Massagegerät
EE04390B1 (et)	2004-12-15	Paikne preparaat dermatoloogiliste seisundite raviks
FI20000863A (fi)	2000-10-13	Uusi hoitomenetelmä
IS6575A (is)	2002-09-30	Hýdroxýfenýl-píperidín-4-ýlíden-metýl-bensamíðafleiður til að meðhöndla sársauka
PT1206436E (pt)	2004-12-31	Retinoides para o tratamento de enfisema
ID29792A (id)	2001-10-11	Formulasi lepas terkendali untuk mengobati corp
AU2002249779A1 (en)	2002-08-12	Method to treat hemophilia
GB9918760D0 (en)	1999-10-13	Topical treatment
IS6574A (is)	2002-09-30	Kínólinýl-píperidín-4-ýlíden-metýl-bensamíðafleiður til að meðhöndla sársauka
IS6563A (is)	2002-09-24	Hýdroxýfenýl-píperasinýl-metýl-bensamíðafleiður til að meðhöndla sársauka
NO20013337L (no)	2001-08-17	Ny behandling
DE60023003D1 (de)	2005-11-10	Haarbehandlungsmittel
DE60037935D1 (de)	2008-03-20	Kontinuierliches behandlungssystem
GB2354944B (en)	2002-10-02	Skin treatment compositions
FI19992741A (fi)	2001-06-22	Karsintalaitteisto
FI4299U1 (fi)	2000-01-19	Saunasuodatin
AU2001272902A1 (en)	2001-12-03	Treating musculoskeletal disorders using lp85 and analogs thereof
EA199901044A1 (ru)	2000-12-25	Аппликатор-массажер
FR2788967B1 (fr)	2001-05-25	Table de massage
FI20000952A0 (fi)	2000-04-20	Menetelmä tuhkan käsittelemiseksi
DE29900728U1 (de)	1999-04-29	Hand-Massagegerät
DE10085032T1 (de)	2002-10-10	Behandlung von Nebenwirkungen